跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16,773 条关于
“Zura Bio Limited”
全部
16,773
临床试验
3,779
药物
1,075
机构
1,597
资讯
10,322
9个月前
Zura Bio Advances Tibulizumab Phase 2 Trials with $139 Million Cash Runway Through 2027
去年
Zura Bio Launches Phase 2 TibuSURE Study of Tibulizumab for Systemic Sclerosis
去年
Zura Bio Launches Phase II TibuSHIELD Trial for Novel Dual-Inhibitor in Hidradenitis Suppurativa
7个月前
Zura Bio Advances Dual-Target Bispecific Tibulizumab Through Phase 2 Trials in Autoimmune Diseases
去年
YD Bio Limited Goes Public on Nasdaq, Advancing DNA Methylation Cancer Detection and Exosome Therapies
3个月前
Oak Hill Bio to Go Public via SPAC Merger, Secures $175 Million to Advance Rugonersen for Angelman Syndrome Through Phase 3
去年
Dupilumab Shows Limited Success in Peanut Allergy Desensitization Study
去年
PharmAust Advances ALS Treatment with New Funding
去年
PARASOL Workshop Suggests Broader Proteinuria Endpoints for FSGS Drug Approval
去年
Hansoh Pharma's HS-20093 Granted Breakthrough Therapy Designation for Lung Cancer
第 1 页,共 1033 页
上一页
下一页